[CAS NO. 1240299-33-5]  AZD3514

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1240299-33-5]

Catalog
AS960482
Brand
Arctom Scientific
CAS
1240299-33-5

DESCRIPTION [1240299-33-5]

Overview

MDL-
Molecular Weight519.56
Molecular FormulaC25H32F3N7O2
SMILESC(F)(F)(F)C=1N2C(=NN1)CCC(=N2)N3CCC(CC3)C4=CC=C(OCCN5CCN(C(C)=O)CC5)C=C4

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.9247 mL9.6235 mL19.2471 mL
5 mM0.3849 mL1.9247 mL3.8494 mL
10 mM0.1925 mL0.9624 mL1.9247 mL
50 mM0.0385 mL0.1925 mL0.3849 mL

Description

AZD3514 is a potent and oral downregulator with of 2.2 μM and has ability of reducing AR protein expression.Phase 1.

Targets

Androgen Receptor [1]
2.2 μM(Ki)

In vitro

AZD3514 binds to the AR ligand binding domain and has selectivity for binding to AR over other nuclear hormone receptors. In vitro AZD3514 inhibits cell growth in prostate cancer cells expressing wild-type (VCaP) and mutated (T877A) AR (LNCaP), but is inactive in AR-negative prostate cancer cells. AZD3514 causes a rapid reduction in PSA synthesis in vitro; with a significant decrease in PSA mRNA being evident in LNCaP cells within 2-3 h of compound treatment. AZD3514 inhibits an androgen-induced translocation of AR from the cytoplasm to the nucleus within a comparable time-frame in LNCaP cells and U2OS AR-transfected cells. AZD3514 treatment also reduces AR protein in LNCaP cells maintained in steroid-depleted conditions; an effect which is evident within 6-8 h, and maximal at 18-24 h.


Synonyms

Ethanone, 1-[4-[2-[4-[1-[7,8-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]-
1-[4-[2-[4-[1-[7,8-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]ethanone
AZD 3514
1-[4-[2-[4-[1-[3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]phenoxy]ethyl]piperazin-1-yl]ethanone
AZD3514
AZD-3514